Cargando…

Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial

PURPOSE: To prospectively evaluate interobserver agreement for small bowel ultrasound (SBUS) in newly diagnosed and relapsing Crohn’s disease. METHODS: A subset of patients recruited to a prospective trial comparing the diagnostic accuracy of MR enterography and SBUS underwent a second SBUS performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatnagar, Gauraang, Quinn, Laura, Higginson, Antony, Plumb, Andrew, Halligan, Steve, Tolan, Damian, Lapham, Roger, Mallett, Susan, Taylor, Stuart A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455580/
https://www.ncbi.nlm.nih.gov/pubmed/32037466
http://dx.doi.org/10.1007/s00261-020-02405-w
_version_ 1783575656706080768
author Bhatnagar, Gauraang
Quinn, Laura
Higginson, Antony
Plumb, Andrew
Halligan, Steve
Tolan, Damian
Lapham, Roger
Mallett, Susan
Taylor, Stuart A.
author_facet Bhatnagar, Gauraang
Quinn, Laura
Higginson, Antony
Plumb, Andrew
Halligan, Steve
Tolan, Damian
Lapham, Roger
Mallett, Susan
Taylor, Stuart A.
author_sort Bhatnagar, Gauraang
collection PubMed
description PURPOSE: To prospectively evaluate interobserver agreement for small bowel ultrasound (SBUS) in newly diagnosed and relapsing Crohn’s disease. METHODS: A subset of patients recruited to a prospective trial comparing the diagnostic accuracy of MR enterography and SBUS underwent a second SBUS performed by one of a pool of six practitioners, who recorded the presence, activity and location of small bowel and colonic disease. Detailed segmental mural and extra-mural observations were also scored. Interobserver variability was expressed as percentage agreement with a construct reference standard, split by patient cohort, grouping disease as present or absent. Prevalence adjusted bias adjusted kappa (PABAK), and simple percentage agreement between practitioners, irrespective of the reference standard, were calculated. RESULTS: Thirty-eight patients (11 new diagnosis, 27 relapse) were recruited from two sites. Overall percentage agreement for small bowel disease presence against the consensus reference was 82% (52–95% (95%CI)), kappa coefficient (κ) 0.64, (substantial agreement) for new diagnosis and 81%, κ 0.63 (substantial agreement) for the relapsing cohort. Agreement for colonic disease presence was 64%, κ 0.27 (fair agreement) in new diagnosis and 78%,κ 0.56 (moderate agreement) in the relapsing cohort. Simple agreement between practitioners was 84% and 87% for small bowel and colonic disease presence respectively. Practitioners agreed on small bowel disease activity in 24/27 (89%) where both identified disease. Kappa agreement for detailed mural observations ranged from κ 0.00 to 1.00. CONCLUSION: There is substantial practitioner agreement for small bowel disease presence in newly diagnosed and relapsing CD patients, supporting wider dissemination of enteric US. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00261-020-02405-w) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7455580
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-74555802020-09-03 Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial Bhatnagar, Gauraang Quinn, Laura Higginson, Antony Plumb, Andrew Halligan, Steve Tolan, Damian Lapham, Roger Mallett, Susan Taylor, Stuart A. Abdom Radiol (NY) Hollow Organ GI PURPOSE: To prospectively evaluate interobserver agreement for small bowel ultrasound (SBUS) in newly diagnosed and relapsing Crohn’s disease. METHODS: A subset of patients recruited to a prospective trial comparing the diagnostic accuracy of MR enterography and SBUS underwent a second SBUS performed by one of a pool of six practitioners, who recorded the presence, activity and location of small bowel and colonic disease. Detailed segmental mural and extra-mural observations were also scored. Interobserver variability was expressed as percentage agreement with a construct reference standard, split by patient cohort, grouping disease as present or absent. Prevalence adjusted bias adjusted kappa (PABAK), and simple percentage agreement between practitioners, irrespective of the reference standard, were calculated. RESULTS: Thirty-eight patients (11 new diagnosis, 27 relapse) were recruited from two sites. Overall percentage agreement for small bowel disease presence against the consensus reference was 82% (52–95% (95%CI)), kappa coefficient (κ) 0.64, (substantial agreement) for new diagnosis and 81%, κ 0.63 (substantial agreement) for the relapsing cohort. Agreement for colonic disease presence was 64%, κ 0.27 (fair agreement) in new diagnosis and 78%,κ 0.56 (moderate agreement) in the relapsing cohort. Simple agreement between practitioners was 84% and 87% for small bowel and colonic disease presence respectively. Practitioners agreed on small bowel disease activity in 24/27 (89%) where both identified disease. Kappa agreement for detailed mural observations ranged from κ 0.00 to 1.00. CONCLUSION: There is substantial practitioner agreement for small bowel disease presence in newly diagnosed and relapsing CD patients, supporting wider dissemination of enteric US. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00261-020-02405-w) contains supplementary material, which is available to authorized users. Springer US 2020-02-10 2020 /pmc/articles/PMC7455580/ /pubmed/32037466 http://dx.doi.org/10.1007/s00261-020-02405-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Hollow Organ GI
Bhatnagar, Gauraang
Quinn, Laura
Higginson, Antony
Plumb, Andrew
Halligan, Steve
Tolan, Damian
Lapham, Roger
Mallett, Susan
Taylor, Stuart A.
Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial
title Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial
title_full Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial
title_fullStr Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial
title_full_unstemmed Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial
title_short Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial
title_sort observer agreement for small bowel ultrasound in crohn’s disease: results from the metric trial
topic Hollow Organ GI
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455580/
https://www.ncbi.nlm.nih.gov/pubmed/32037466
http://dx.doi.org/10.1007/s00261-020-02405-w
work_keys_str_mv AT bhatnagargauraang observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial
AT quinnlaura observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial
AT higginsonantony observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial
AT plumbandrew observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial
AT halligansteve observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial
AT tolandamian observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial
AT laphamroger observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial
AT mallettsusan observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial
AT taylorstuarta observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial
AT observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial